DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ advanced 1.03% to $758.27 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.25% to 7,651.54 and Dow Jones Industrial Average falling 0.86% to 50,906.05.
The stock's rise snapped a five-day losing streak.
Regeneron Pharmaceuticals Inc. closed 11.76% short of its 52-week high of $859.34, which the company reached on September 3rd.
The stock outperformed some of its competitors Wednesday, as Amgen Inc. $(AMGN)$ fell 0.50% to $421.51, Moderna Inc. (MRNA) fell 5.35% to $192.57, and Gilead Sciences Inc. (GILD) fell 1.47% to $149.05.
Trading volume (867,606) eclipsed its 50-day average volume of 759,640.
Data source: Dow Jones Market Data, FactSet. Data compiled September 30, 2026.